EDSA Fundamental Analysis - EDESA BIOTECH INC

Fundamental Rating

We assign a fundamental rating of 3 out of 10 to EDSA. EDSA was compared to 558 industry peers in the Biotechnology industry. While EDSA has a great health rating, there are worries on its profitability. EDSA is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year EDSA has reported negative net income.

EDSA had a negative operating cash flow in the past year.

In the past 5 years EDSA always reported negative net income.

EDSA had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

EDSA has a Return On Assets of -35.48%. This is in the better half of the industry: EDSA outperforms 60.75% of its industry peers.

EDSA has a Return On Equity of -37.57%. This is in the better half of the industry: EDSA outperforms 72.22% of its industry peers.

		Industry Rank	Sector Rank
ROA	-35.48%
ROE	-37.57%
ROIC	N/A

ROA(3y)-135.86%

ROA(5y)-111.64%

ROE(3y)-205.71%

ROE(5y)-157.84%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for EDSA so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

EDSA has more shares outstanding than it did 1 year ago.

EDSA has more shares outstanding than it did 5 years ago.

There is no outstanding debt for EDSA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

An Altman-Z score of 4.55 indicates that EDSA is not in any danger for bankruptcy at the moment.

EDSA's Altman-Z score of 4.55 is fine compared to the rest of the industry. EDSA outperforms 76.70% of its industry peers.

EDSA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	4.55

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

EDSA has a Current Ratio of 15.73. This indicates that EDSA is financially healthy and has no problem in meeting its short term obligations.

The Current ratio of EDSA (15.73) is better than 89.07% of its industry peers.

EDSA has a Quick Ratio of 15.73. This indicates that EDSA is financially healthy and has no problem in meeting its short term obligations.

EDSA has a better Quick ratio (15.73) than 89.07% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	15.73
Quick Ratio	15.73

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

EDSA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 34.30%, which is quite impressive.

EPS 1Y (TTM)34.3%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%48.28%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

EDSA is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -0.31% yearly.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y26.01%

EPS Next 2Y-3.83%

EPS Next 3Y-0.31%

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for EDSA. In the last year negative earnings were reported.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for EDSA. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-3.83%

EPS Next 3Y-0.31%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

EDSA does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

EDESA BIOTECH INC

NASDAQ:EDSA (7/15/2025, 12:47:09 PM)

2.19

-0.01 (-0.45%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences

GICS IndustryBiotechnology

Earnings (Last)05-14 2025-05-14/amc

Earnings (Next)08-07 2025-08-07

Inst Owners43.53%

Inst Owner Change0%

Ins Owners22.93%

Ins Owner Change69.13%

Market Cap15.37M

Analysts82.5

Price Target15.98 (629.68%)

Short Float %0.5%

Short Ratio0.96

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)-25.75%

Min EPS beat(2)-51.8%

Max EPS beat(2)0.3%

EPS beat(4)3

Avg EPS beat(4)1.99%

Min EPS beat(4)-51.8%

Max EPS beat(4)47.35%

EPS beat(8)7

Avg EPS beat(8)17.8%

EPS beat(12)11

Avg EPS beat(12)26.51%

EPS beat(16)14

Avg EPS beat(16)22.91%

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)-17.54%

EPS NQ rev (1m)1.69%

EPS NQ rev (3m)1.69%

EPS NY rev (1m)-5.66%

EPS NY rev (3m)-5.66%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	N/A
P/FCF	N/A
P/OCF	N/A
P/B	0.99
P/tB	1.14
EV/EBITDA	N/A

EPS(TTM)-1.59

EYN/A

EPS(NY)-2.08

Fwd EYN/A

FCF(TTM)-0.82

FCFYN/A

OCF(TTM)-0.82

OCFYN/A

SpS0

BVpS2.21

TBVpS1.92

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-35.48%
ROE	-37.57%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM	N/A

ROA(3y)-135.86%

ROA(5y)-111.64%

ROE(3y)-205.71%

ROE(5y)-157.84%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score6

Asset Turnover0

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	15.73
Quick Ratio	15.73
Altman-Z	4.55

F-Score6

WACCN/A

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)34.3%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%48.28%

EPS Next Y26.01%

EPS Next 2Y-3.83%

EPS Next 3Y-0.31%

EPS Next 5YN/A

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y23.94%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y52.38%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y52.37%

OCF growth 3YN/A

OCF growth 5YN/A

EDESA BIOTECH INC (EDSA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens